Ethyl Indole-2-Carboxylate CAS 3770-50-1 Purity > 98.5% (GC) Hoobkas High Quality Featured duab

Ethyl Indole-2-Carboxylate CAS 3770-50-1 Purity > 98.5% (GC) Hoobkas Zoo

Lus piav qhia luv luv:

Lub npe tshuaj: Ethyl Indole-2-Carboxylate

CAS: 3770-50-1 Nr

Purity:> 98.5% (GC)

Cov tsos mob: Tawm-dawb mus rau daj hmoov

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Xa email rau peb

Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chaw tsim tshuaj paus Supply nrog High Quality, Commercial Production
Lub npe tshuaj: Ethyl Indole-2-Carboxylate CAS: 3770-50-1

Chemical Properties:

Tshuaj npe	Ethyl Indole-2-Carboxylate
Synonyms	Indole-2-Carboxylic Acid Ethyl Ester;Ethyl 1H-Indole-2-Carboxylate;2-Ethoxycarbonylindole
CAS Nr	3770-50-1 : kuv
CAT Number	Qauv TSIS MUAJ: RF-PI1481
Tshuag xwm txheej	Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula	C11H11NO2
Molecular Luj	189.21 Nws
Hom	Ruifu Tshuaj

Specifications:

Yam khoom	Specifications
Qhov tshwm sim	Off-White to Yellowish Powder
Purity / Analysis Method	> 98.5% (GC)
Melting Point	115.0 ~ 125.0 ℃
Poob rau ziab	≤0.50%
Tag nrho cov impurities	<1.50%
Test Standard	Enterprise Standard
Kev siv	Pharmaceutical Intermediates

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.

Qhov zoo:

FAQ:

Daim ntawv thov:

Ethyl Indole-2-Carboxylate (CAS: 3770-50-1) yog lub tsev thaiv uas tau siv los ua cov tshuaj reactant rau kev npaj ntawm pyridazinoindole derivatives uas muaj cov tshuaj tua kab mob.Siv los ua tshuaj intermediates hauv kev sib txuas ntawm angiotensin converting enzyme inhibitors (ACEIs).Reactant rau kev npaj ntawm: CRTH2 receptor antagonists;Indoleamine 2,3-dioxygenase (IDO) inhibitors;Cannabinoid CB1 receptor antagonists;Inhibitors ntawm Human Reticulocyte 15-Lipoxygenase-1;N-(benzoylphenyl)-1H-indole-2-carboxamides ua cov tshuaj tiv thaiv hypertriglyceridemic muaj zog;Cov tshuaj tiv thaiv kab mob tiv thaiv tib neeg cov kab mob leukemia K562 hlwb; Inhibitors ntawm p38 MAP kinase;Acetolactate synthase inhibitors.